Associate Professor Michael Hofman is a nuclear medicine physician at the Centre for Cancer Imaging at the Peter MacCallum Cancer Centre in Melbourne, Australia's only public hospital dedicated to cancer treatment, research and education. He has a broad interest in positron emission tomography (PET), molecular imaging applications in oncology and radionuclide therapy. He has a vision of improving patient outcomes by using molecular imaging to non-invasively characterise disease thereby enabling improved selection of the most appropriate therapy for an individual patient and better assessment of therapeutic response. He has particular interest in novel F-18 and Ga-68 PET radiotracers, and theranostic applications including neuroendocrine tumours. He has an interest in training the next generation of nuclear medicine specialists and currently serves as the RACP representative on the Joint Specialty Advisory Committee in Nuclear Medicine. He currently serves as an associate editor for Cancer Imaging, the Journal of Medical Imaging and Radiation Oncology, the American Journal of Nuclear Medicine and Molecular Imaging and Leukemia Lymphoma.